Observational Study on Efficacy on Glycaemic Control of Slow-Acting Insulin Analogue in Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIGHT
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 14 Oct 2009 Actual end date changed from Aug 2008 to Nov 2008 as reported by ClinicalTrials.gov.
- 16 Sep 2008 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.